v3.25.2
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES    
Net Loss $ (3,980,820) $ (4,142,666)
Adjustments to Reconcile Net Loss to Net Cash Used by Operating Activities    
Depreciation and Amortization 31,805 19,753
Stock Option Compensation 122,600 104,600
Common Stock Warrants Issued for Services 2,700
Common Stock issued for Services 90,000 138,546
Loss from Iveda Phils Joint Venture 180,000
(Increase) Decrease in Operating Assets    
Accounts Receivable (996,586) 930,803
Deferred Cost of Goods (507,308)
Inventory 176,395 199,124
Other Current Assets 528 (66,995)
Other Assets 203,693 (175,592)
Increase (Decrease) in Accounts and Other Payables 439,945 (523,633)
Net Cash Used in Operating Activities (4,419,748) (3,333,360)
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchase of Property and Equipment (2,608) (85,593)
Investment in Iveda Phils Joint Venture   (180,000)
Net Cash Used in Investing Activities (2,608) (265,593)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from (Payments on) Short-Term Notes Payable/Debt 78,254 (47,554)
Proceeds from (Payments to) Long-Term Debt 498,195 (251,498)
Common Stock Issued, Net of (Cost of Capital) 1,683,970 1,322,885
Net Cash Provided by Financing Activities 2,260,419 1,023,833
EFFECT OF EXCHANGE RATE CHANGES ON CASH (48,045) 1,780
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (2,209,982) (2,573,340)
Cash and Cash Equivalents- Beginning of Period 4,868,282 7,441,622
CASH AND CASH EQUIVALENTS - END OF PERIOD 2,658,300 4,868,282
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION    
Interest Paid 15,316 9,793
Income Tax Paid $ 38,544 $ 28,779